Scientific article
OA Policy
English

Thyroxine treatments do not correct inner ear defects in tmprss1 mutant mice

Published inNeuroreport, vol. 21, no. 13, p. 897-901
Publication date2010
Abstract

Complete deficiency of a member of the type II transmembrane serine protease family, tmprss1 (also known as hepsin), is associated with severe to profound hearing loss in mice and a gross enlargement of the tectorial membrane in the cochlea. Levels of thyroxine in these mice have been shown to be significantly lower when compared with wild-type controls. As thyroxine is critical for inner ear development, we delivered thyroxine to these mice during the prenatal or postnatal stage of development. Both the treatments could not ameliorate hearing loss or correct deformities in the tectorial membrane of these mutant mice, suggesting that a deficiency in tmprss1 affects thyroxine responsiveness in the inner ear in vivo.

Keywords
  • Animals
  • Ear Diseases/congenital/*drug therapy/pathology
  • Ear, Inner/*abnormalities/pathology
  • Hearing/physiology
  • Hearing Tests
  • Mice
  • Mice, Knockout
  • Mutation/physiology
  • Reverse Transcriptase Polymerase Chain Reaction
  • Serine Endopeptidases/*genetics/physiology
  • Thyroxine/*therapeutic use
Citation (ISO format)
HANIFA, Syazana et al. Thyroxine treatments do not correct inner ear defects in tmprss1 mutant mice. In: Neuroreport, 2010, vol. 21, n° 13, p. 897–901. doi: 10.1097/WNR.0b013e32833dbd2d
Main files (1)
Article (Accepted version)
accessLevelPublic
Identifiers
Journal ISSN0959-4965
608views
593downloads

Technical informations

Creation22/05/2012 15:16:01
First validation22/05/2012 15:16:01
Update14/03/2023 17:30:37
Status update14/03/2023 17:30:37
Last indexation29/10/2024 19:52:16
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack